cp wire

CP Wire Articles

Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy

  • Factor XIa inhibitor moving into Phase 2 Trials for Secondary Stroke Prevention
  • Factor Xia was first noticed as a potential approach to thrombosis because people with little... read more
Mon, 04/16/18 - 07:28 pm
More Promising Data from Innovation Pharmaceutical's Phase 2 Brilacidin Oral Mucositis Study
  • Median Duration of Severe Oral Mucositis (SOM) Reduced to Less Than One Day
  • No Unplanned Office Visits, Emergency Department Visits, and/or Hospital Admissions Due to OM in... read more
Mon, 04/16/18 - 01:44 pm
CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease


New Data from CytoReason published in Gut outlines the role of a new technological platform approach that has revealed a new blood-based biomarker that is 94% accurate in pretreatment... read more

Mon, 04/16/18 - 01:29 pm
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study

  • Showed that treatment with esketamine resulted in a statistically significant, clinically meaningful... read more

Mon, 04/16/18 - 01:18 pm
FDA Now Accepts Alkermes Application It Rejected Two Weeks Ago

Alkermes today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ALKS 5461, a novel, once-daily, oral investigational medicine... read more

Mon, 04/16/18 - 08:50 am

Pages